Psychological Distress among Hospitalized COVID-19 Patients in Denmark during the First 12 Months of the Pandemic

Moseholm, Ellen; Midtgaard, Julie; Bollerup, Signe; Apol, Ása Didriksen; Olesen, Oskar B.; Jespersen, Sofie; Weis, Nina

doi:10.3390/ijerph191610097

Cited by 9 publications

(12 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The gradual adaptation process was reflected in COVID-19 patients' attitudes upon admission, from uncertainty about the disease to anticipation and suspicion of the examinations, to confrontation and acceptance following the diagnosis, which ultimately culminated in gratitude for the experience ( 14 ). This study also identified a significant reduction in symptom burden associated with depression and anxiety over time with hospitalization ( 15 ). However, cases who had been gradually improving physically and psychologically with the treatment appeared to experience changes in their psychological state after experiencing a re-positive result.…”

Section: Discussionmentioning

confidence: 77%

The changes in psychological symptoms of COVID-19 patients after “re-positive”

Wang

Fan²,

et al. 2022

Front. Psychiatry

View full text Add to dashboard Cite

BackgroundPrevious studies have showed that individuals infected with COVID-19 were more likely to report psychological symptoms. However, little is known about the changes from testing positive to negative to positive again.MethodsThis survey was conducted through the questionnaires including the 7-item Generalized Anxiety Disorder (GAD-7), the 9-item Patient Health Questionnaire (PHQ-9), as well as the Self-Rating Scale of Sleep (SRSS) to explore the psychological status of COVID-19 and re-positive cases.″re-positive″ is defined as a positive RT-PCR test at any time during the recovery period after testing negative.ResultsA total of 94 COVID-19 patients presented the prevalence rates of anxiety, depression, insomnia, and any of the three psychological symptoms being 26.6, 8.6, 12.8, and 31.9%, respectively. Among these, 32 cases were re-tested positive during the recovery period, with the prevalence rates of anxiety, depression, insomnia, and any of the three psychological symptoms being 21.9, 18.7, 31.2, and 37.5%, respectively. The psychological status after re-positive showed a significant decrease in anxiety (P = 0.023), an increase in depression, and a significant rise in insomnia (P = 0.035). For those with no psychological symptoms during initial-positive, after re-positive, 5.88% reported anxiety, 5.88% reported depression, and 11.76% reported insomnia. For those who experienced only anxiety symptoms during initial-positive, after re-positive, 33.3% reported depression, and 33.3% reported insomnia.ConclusionsOur findings encompassed the urgent concern for anxiety in initial-positive COVID-19 patients, depression in re-positive COVID-19 patients, and insomnia in both initial and re-positive patients, hence enabling targeted interventions for appeasing the psychological burden of COVID-19 patients.

show abstract

Section: Discussionmentioning

confidence: 77%

The changes in psychological symptoms of COVID-19 patients after “re-positive”

Wang

Fan²,

et al. 2022

Front. Psychiatry

View full text Add to dashboard Cite

show abstract

“…Twelve studies 17,22,24,26,29,33,34,36,42,44,45,47 used 12 different mental health-related measures: the Patient Health Questionnaire-9 (PHQ-9; N = 3), the Hospital and Anxiety Depression Scale (HADS; N = 2), Generalised Anxiety Disorder-7 (GAD-7; N = 2), the Beck Anxiety Inventory (BAI; N = 1), the Beck Depression Inventory (BDI; N = 1), the Child Depression Inventory (CDI, N = 1), the Child Post-Traumatic Stress Reaction Index (CPTS-RI; N = 1), the Harvard Trauma Questionnaire (HTQ; N = 1), the Perceived Stress Scale (PSS-10; N = 1), the Screen for Child Anxiety Related Disorders (SCARED; N = 1), the Self-Rating Anxiety Scale (SAS; N = 1) and the Self-Rating Depression Scale (SDS; N = 1). Twelve studies used one or more sleep-related QOL measures, 13,17,23,26,29,[33][34][35][36]42,44,47 with the most popular being the Pittsburgh Sleep Quality Index (PSQI; N = 8).…”

Section: Resultsmentioning

confidence: 99%

“…Search terms were developed with reference to Arber et al 11 by two authors, one a health economist (EW) and one an information specialist (NK). The search terms centred around the concepts of hospital patients, COVID-19 and health utility measures, including qualityadjusted life-years (QALYs), disability-adjusted life-years (DALYs) and survey measures such as EQ-5D, the Short Form (36) Health Survey (SF-36) and the Health Utilities Index (HUI). A full list of search strategies is included in the Appendix.…”

Section: Methodsmentioning

confidence: 99%

Evidence of quality of life for hospitalised patients with COVID-19: a scoping review

Webb,

King,

Howdon

et al. 2024

Health Technol Assess

View full text Add to dashboard Cite

Background Information on the quality of life of people hospitalised with COVID-19 is important, both in assessing the burden of disease and the cost-effectiveness of treatments. However, there were potential barriers to collecting such evidence. Objective To review the existing evidence on quality of life for people hospitalised with COVID-19, with a focus on the amount of evidence available and methods used. Design A scoping review with systematic searches. Results A total of 35 papers were selected for data extraction. The most common study type was economic evaluation (N = 13), followed by cross-sectional (N = 10). All economic evaluations used published utility values for other conditions to represent COVID-19 inpatients’ quality of life. The most popular quality-of-life survey measure was the Pittsburgh Sleep Quality Index (N = 8). There were 12 studies that used a mental health-related survey and 12 that used a sleep-related survey. Five studies used EQ-5D, but only one collected responses from people in the acute phase of COVID-19. Studies reported a negative impact on quality of life for people hospitalised with COVID-19, although many studies did not include a formal comparison group. Limitations Although it used systematic searches, this was not a full systematic review. Conclusion Quality-of-life data were collected from people hospitalised with COVID-19 from relatively early in the pandemic. However, there was a lack of consensus as to what survey measures to use, and few studies used generic health measures. Economic evaluations for COVID-19 treatments did not use utilities collected from people with COVID-19. In future health crises, researchers should be vigilant for opportunities to collect quality-of-life data from hospitalised patients but should try to co-ordinate as well as ensuring generic health measures are used more. Funding This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR132254.

show abstract

“…These findings are consistent with a previous study which demonstrated a decrease in the symptoms of depression and anxiety whereas increased symptoms of insomnia among COVID-19 patients over time [ 64 ]. Additionally, another study indicated that there was no significant change in insomnia over time among COVID-19 patients [ 65 ]. Several factors may contribute to this pattern of insomnia exhibiting a different pattern than other symptoms of mental ill-health.…”

Section: Discussionmentioning

confidence: 99%

Trajectories of mental health outcomes following COVID-19 infection: a prospective longitudinal study

Badinlou,

Rahimian,

Hedman-Lagerlöf

et al. 2024

BMC Public Health

View full text Add to dashboard Cite

Background The COVID-19 pandemic has triggered a global mental health crisis. Yet, we know little about the lasting effects of COVID-19 infection on mental health. This prospective longitudinal study aimed to investigate the trajectories of mental health changes in individuals infected with COVID-19 and to identify potential predictors that may influence these changes. Methods A web-survey that targeted individuals that had been infected with COVID-19 was used at three time-points: T0 (baseline), T1 (six months), and T2 (twelve months). The survey included demographics, questions related to COVID-19 status, previous psychiatric diagnosis, post-COVID impairments, fatigue, and standardized measures of depression, anxiety, insomnia. Linear mixed models were used to examine changes in depression, anxiety, and insomnia over time and identify factors that impacted trajectories of mental health outcomes. Results A total of 236 individuals completed assessments and was included in the longitudinal sample. The participants’ age ranged between 19 and 81 years old (M = 48.71, SD = 10.74). The results revealed notable changes in mental health outcomes over time. The trajectory of depression showed significant improvement over time while the trends in anxiety and insomnia did not exhibit significant changes over time. Younger participants and individuals who experienced severe COVID-19 infection in the acute phase were identified as high-risk groups with worst mental ill-health. The main predictors of the changes in the mental health outcomes were fatigue and post-COVID impairments. Conclusions The findings of our study suggest that mental health outcomes following COVID-19 infection exhibit a dynamic pattern over time. The study provides valuable insights into the mental health trajectory following COVID-19 infection, emphasizing the need for ongoing assessment, support, and interventions tailored to the evolving mental health needs of this population.

show abstract

Psychological Distress among Hospitalized COVID-19 Patients in Denmark during the First 12 Months of the Pandemic

Cited by 9 publications

References 49 publications

The changes in psychological symptoms of COVID-19 patients after “re-positive”

The changes in psychological symptoms of COVID-19 patients after “re-positive”

Evidence of quality of life for hospitalised patients with COVID-19: a scoping review

Trajectories of mental health outcomes following COVID-19 infection: a prospective longitudinal study

Contact Info

Product

Resources

About